Posted on Leave a comment

Germany’s Cannabis Legalization: A Domino Effect for Europe?

Germany’s Cannabis Legalization: A Domino Effect for Europe?

Germany’s recent legalization of cannabis for adult recreational use has sent shockwaves through Europe, reigniting the debate on drug policy reform across the continent. This decision puts pressure on other European nations to re-evaluate their own cannabis laws, for several reasons:

Economic Disparity and the “Green Rush”:

  • Unfair Advantage: With a legal cannabis market, Germany positions itself to reap significant tax revenue and create new jobs in cultivation, processing, and retail sectors. This could create an unfair economic advantage over neighboring countries where cannabis remains illegal.
  • The Tourist Factor: Legal cannabis in Germany might attract tourists seeking cannabis experiences, potentially harming tourism industries in countries with stricter laws.

Beyond Economics: Public Health and Safety:

  • Zero Cannabis Deaths: Proponents of legalization argue that criminalization has failed to curb cannabis use. They point out the absence of documented deaths directly attributable to cannabis use, unlike alcohol or tobacco.
  • Stress Relief and Medical Benefits: Cannabis legalization acknowledges the potential benefits of the plant for stress relief, pain management, and other medical conditions. This aligns with a growing public sentiment towards exploring alternative therapies.

Decriminalization vs. Legalization:

  • A Stepping Stone: Germany’s move might encourage other European nations to consider decriminalization as a first step. Decriminalization removes criminal penalties for possession and use, focusing on regulation and public health initiatives.

The Hemp Opportunity:

  • Industrial Powerhouse: The legalization of cannabis also shines a light on the vast potential of industrial hemp, a close relative of marijuana. Hemp cultivation can create new agricultural opportunities and promote sustainable practices in various industries.

A Look Towards the Future:

The future of cannabis legalization in Europe hinges on a few key factors:

  • Monitoring the German Experiment: Other European nations will likely closely monitor the social and economic impacts of legalization in Germany before making policy changes.
  • Standardization and Regulation: If a domino effect occurs, Europe will need to establish standardized regulations for cannabis production, distribution, and consumption across borders.
  • Public Education: Public education campaigns will be crucial to dispel myths about cannabis and promote responsible use among adults.

Germany’s bold move has undoubtedly reignited the cannabis debate in Europe. While the full impact remains to be seen, one thing is certain: the conversation around responsible cannabis regulation has reached a tipping point.

Posted on Leave a comment

Germany Legalizes Recreational Cannabis: A Seismic Shift in the European Market

A Historic Move:

On March 22nd, 2024, Germany made history by becoming the first major European nation to legalize recreational cannabis for adults. This landmark decision marks a significant shift in European cannabis policy and is sure to have ripple effects across the continent.

Legal Framework:

The new law allows adults over 18 to purchase and possess up to 25 grams of cannabis and cultivate up to three plants for personal use at home. Additionally, a system of licensed cannabis cultivation associations (CCAs) will be established, allowing members to acquire cannabis for recreational purposes.

Market Opportunities:

This legalization opens up a vast new market for the European cannabis industry. Estimates suggest the German market could reach €5 billion by 2027, creating significant opportunities for businesses involved in cultivation, processing, distribution, and retail of cannabis products.

Impact on Neighboring Countries:

Germany’s legalization is likely to trigger a domino effect in neighboring countries. Nations like France, Italy, and Switzerland are already revisiting their cannabis policies, with some potentially considering similar legalization measures.

Challenges and Considerations:

Despite the excitement, some challenges remain. Regulatory frameworks need to be developed to ensure responsible production, distribution, and consumption. Additionally, potential issues like driving under the influence and youth access need to be addressed.

Overall Significance:

Germany’s legalization is a watershed moment for the European cannabis industry. It paves the way for a more regulated and responsible cannabis market, potentially leading to increased tax revenue and economic growth. It also provides a model for other European countries considering cannabis reform.

Looking Forward:

The coming months will be crucial as Germany rolls out its legalization framework. The industry will be watching closely to see how the regulations are implemented and how the market develops. This could be a turning point for the European cannabis landscape, potentially ushering in a new era of acceptance and responsible cannabis use.

Posted on Leave a comment

EIHA: Hemp in Europe: The situation of hemp today  

Hemp in Europe

The situation of hemp today  

Today, the Common Agriculture Policy is responsible for establishing the maximum THC level allowed for industrial hemp on the field. Many EU countries still prohibit or have unclear regulations about the use and marketing of flowers, incorrectly considered as narcotic, even if the THC level is below the established thresholds in the EU regulation for industrial hemp. In order for hemp to be a profitable crop, farmers need to be allowed to maximise their income through the utilisation of the whole plant, especially the flowers and leaves. That is why, EIHA defends a “whole plant” approach (#unlockthepotential).

Hemp transformers source 90% of their raw material within Europe. More than half of flowers and leaves traded in Europe are used for the production of food supplements, including CBD extracts. When it comes to textiles, because of the relatively high raw material prices, the lack of fibre supply and the scarcity of manufacturing facilities, production is limited as it mainly represents a niche market. A huge consumers market existed for hemp fibres until after World War II. Just to give you an idea, in the 1930s Russia’s hemp area sown was almost 700,000 hectares, providing for 40% of Europe’s hemp needs. In comparison, Italy and Yugoslavia accounted for up to 100,000 hectares each. Currently the EU combined barely grows 50,000 hectares. France is currently the biggest producer, followed by Italy and the Netherlands.

Even though Europe has not unlocked the full potential of hemp, the industry is rapidly growing.  In fact, from 2013 to 2018, there was a 70% increase in the number of hectares dedicated to industrial hemp cultivation in Europe. If we compare it to 1993 figures, the number of hectares has increased 614% since.

Find more information about hemp production here!

EIHA Website

Posted on Leave a comment

Europe: Citizens’ initiative to improve access to medical use of cannabis

Europe: Citizens’ initiative to improve access to medical use of cannabis

14 th March 2024

 

The European Commission has approved the registration of a multinational initiative to promote access to medical use of cannabis and encourage research into the plant’s therapeutic potency. That means signature collection can start. Petitioners have six months to launch the initiative and must then collect one million signatures from at least seven member states within a year to force the European Union to consider the proposal.

One objective asks the commission to “promote access to medicinal cannabis and allow the transport of cannabis and its derivatives prescribed for therapeutic purposes to ensure the full enjoyment of the right to health”. Another objective asks the EU to “allocate the necessary funds for research on cannabis for therapeutic purposes”.

European Commission of 6 February 2024

Partner organisation of PGMCG

Marian Hutten, president and founder of PGMCG

Nominated as Patient Ambassador of the IACM 2018-2023

Dutch Patient delegate and translator of the IACM
The International Association for Cannabinoid Medicines
CannabisMedOrg
Bonn, Germany

 

Also read: (dutch)

 

Europa: Burgerinitiatief voor de verbetering van de toegang tot het medicinale gebruik van cannabis